Compound Sodium Alginate Oral Suspension sachet

DRUG2 trials

Sponsors

Reckitt Benckiser Healthcare (UK) Limited

Conditions

Gastro-esophageal Reflux Disease (GERD)

Phase 3

Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients

TerminatedNCT02619747

Reckitt Benckiser Healthcare (UK) LimitedGastro-esophageal Reflux Disease (GERD)

Start: 2014-04-30End: 2017-03-31Updated: 2017-10-06

Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study

CompletedNCT02623062

Reckitt Benckiser Healthcare (UK) LimitedGastro-esophageal Reflux Disease (GERD)

Start: 2013-12-31End: 2016-05-31Updated: 2016-06-03